About BIO
BIO was founded in 1993 and is based in Washington D.C. under the leadership of President and CEO, James C. Greenwood. Joshua Boger, PhD, President & CEO, Vertex Pharmaceuticals Incorporated, is the current Chairman.
BIO Mission Statement
Biotechnology researchers expand the boundaries of science to benefit mankind by providing better healthcare, enhanced agriculture, and a cleaner and safer environment.
The mission of the Biotechnology Industry Organization (BIO) is to be the champion of biotechnology and the advocate for its member organizations-both large and small.
BIO Membership
Corporate R&D members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. The majority of our members are small companies- 90 percent have annual revenues of $25 million or less, reflecting the broader biotechnology industry. BIO also represents academic centers, state and regional biotech associations and service providers to the industry, including financial and consulting firms.
- R&D-Intensive Companies: 68%. Of those:
· 90% have annual revenues under $25 million
· 5% have annual revenues between $25 million and $1 billion
· 5% have annual revenues over $1 billion - Nonprofit/Academic: 15%
- Service Providers: 12%
- State/International Affiliate Organizations: 5%
BIO International Convention
BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
The BIO International Convention showcases the many ways the biotechnology and life science industries work together to help heal, fuel, and feed the world. In 2009, more than 20,000 people from across the globe are expected to converge in Atlanta, Ga. on May 18-21 to attend the global event for biotechnology.
